Allarity Therapeutics, Inc. (ALLR)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.78M |
| Enterprise value | 5.66M |
| Trailing P/E | 0.00 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 2.35 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -0.50 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.24 |
| 52-week change 3 | -99.59% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 377.6000 |
| 52-week low 3 | 1.2700 |
| 50-day moving average 3 | 5.7433 |
| 200-day moving average 3 | 17.0520 |
Share statistics
| Avg vol (3-month) 3 | 523.26k |
| Avg vol (10-day) 3 | 2.87M |
| Shares outstanding 5 | 1.95M |
| Implied shares outstanding 6 | 1.95M |
| Float 8 | 308.66k |
| % held by insiders 1 | 0.02% |
| % held by institutions 1 | 0.94% |
| Shares short (15 Apr 2024) 4 | 105.06k |
| Short ratio (15 Apr 2024) 4 | 0.08 |
| Short % of float (15 Apr 2024) 4 | 5.40% |
| Short % of shares outstanding (15 Apr 2024) 4 | 5.40% |
| Shares short (prior month 15 Mar 2024) 4 | 30.71k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:20 |
| Last split date 3 | 09 Apr 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -81.08% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -17.09M |
| Net income avi to common (ttm) | -20.42M |
| Diluted EPS (ttm) | -205.2000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 222k |
| Total cash per share (mrq) | 0.72 |
| Total debt (mrq) | 1.3M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.14 |
| Book value per share (mrq) | -15.26 |
Cash flow statement
| Operating cash flow (ttm) | -12.74M |
| Levered free cash flow (ttm) | -5.47M |
© 2024 Yahoo. All rights reserved.